4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-20-002862
Chief Financial Officer bought 142,000 shares at $2.04 ($289,680)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-24 | Purchase : show line 1 in the form | +142,000 | $2.04 | $289,680 | 142,000 | D |
| Open-market purchases · 142,000 sh · avg $2.04 · $289,680 | ||||||
Loading xslF345X03/ownership.xml…